CATX

Perspective Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

31.6%

Short % Float

25.6d to cover · High squeeze

86.8%

Inst % Float

10 holders · 2026-06-30

Blackrock Inc.

Top Holder

8.3% of float

74.3M sh

Public Float

31/100

Dilution Score

Medium

66 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

31/100

MEDIUM

Inst: 86.82% · Top: Blackrock Inc.

Biotech Analytics

Oncology

35.3

Squeeze risk: HIGHBiotech Grade: D

Insider Buying0

Publications100

Dilution Risk31

Clinical Trials50

Short Interest90